《美股業績》雪佛龍(CVX.US)第三季盈利增長兩倍 勝預期
雪佛龍(CVX.US)第三季盈利增長兩倍至112億美元,每股盈利為5.78美元,遠高於市場預期的4.86美元,受惠於全球對石油及天然氣需求飆升以及美國油田產量增加。
上季石油與天然氣業務經營溢利飆升81%至93億美元,煉油業務近乎增長一倍至25億美元。美國二疊紀盆地產量超過每日70萬桶,按年增加12%,雪佛龍重申在2025年每日開採100萬桶的目標,並在2023年至2026年期間實現3%的年復合增長率。
季內營運現金流飆升至創紀錄的153億美元,資本回報率升至25%。雪佛龍承諾將利潤用於提高派息、化石燃料與清潔能源項目以及削減債務,預計明年將項目開支將增加20%至170億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.